14 reports

AS OF MARCH 2009, IT WAS IN PRECLINICAL STAGE FOR LISTERIOSIS AND MALARIA.

  • Digestive System Disorder
  • Hospital
  • Immunotherapy
  • Product Initiative
  • TaiwanJ Pharmaceuticals Co., Ltd.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Therapy
  • Product Initiative
  • GlaxoSmithKline plc

## ## ## ## ## ## Germany ## ## ## ## ## ## Japan ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## Italy ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a tim

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • Gastrointestinal Drug
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • Product Initiative

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative

Diarrhea - Overview Diarrhea - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIARRHEA, H## 2019 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIARRHEA, H## 2019 Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ##

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Vaccine
  • Product Initiative

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • United States
  • Product Initiative

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Clinical Trial profile. 99 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Product Initiative

IT PROVIDES RESEARCH PROGRAMS ON BIO-ANTIBIOTICS, COMBINATION PROBIOTICS, LYSOSTAPHIN, CHIKUNGUNYA VACCINE, TYPHOID CONJUGATE VACCINE, ORAL ROTAVIRUS VACCINE, MALARIA VACCINE AND LIQUID RABIES VACCINES, AMONG OTHERS.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • Product Initiative

Phase ## clinical trials of a malaria transmission-blocking vaccine and a hookworm vaccine are underway, both of which are non-commercial products fully funded by third parties.

  • Digestive System Disorder
  • Research And Development
  • Therapy
  • Product Initiative
  • Genfit SA

Patients will be randomized ##:##:## to one of placebo, ## mg of OCA, or ## mg of OCA, taken once daily.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

In vitro and in vivo studies have shown potent activity against S. pneumoniae as well as an extended spectrum of activity against community-acquired methicillin resistant S. aureus (CA-MRSA), streptococci, haemophilus, enterococci, Mycobacterium avium and in animal models of malaria.

  • Clinical Trial
  • Digestive System Disorder
  • World
  • Product Initiative
  • Gilead Sciences, Inc.

PNEUMONIAE AS WELL AS AN EXTENDED SPECTRUM OF ACTIVITY AGAINST CA-MRSA, STREPTOCOCCI, HAEMOPHILUS, ENTEROCOCCI, MYCOBACTERIUM AVIUM AND IN ANIMAL MODELS OF MALARIA.

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • World
  • Product Initiative